In last trading session, Gossamer Bio Inc (NASDAQ:GOSS) saw 1.04 million shares changing hands with its beta currently measuring 1.84. Company’s recent per share price level of $0.71 trading at $0.0 or -0.35% at ring of the bell on the day assigns it a market valuation of $160.05M. That closing price of GOSS’s stock is at a discount of -164.79% from its 52-week high price of $1.88 and is indicating a premium of 36.62% from its 52-week low price of $0.45. Taking a look at company’s average trading volume volume of 1.40 million if we extend that period to 3-months.

Gossamer Bio Inc (NASDAQ:GOSS) trade information

Upright in the red during last session for losing -0.35%, in the last five days GOSS remained trading in the red while hitting it’s week-highest on Wednesday, 05/01/24 when the stock touched $0.71 price level, adding 5.33% to its value on the day. Gossamer Bio Inc’s shares saw a change of -22.47% in year-to-date performance and have moved -0.11% in past 5-day. Gossamer Bio Inc (NASDAQ:GOSS) showed a performance of -38.48% in past 30-days.

Gossamer Bio Inc (GOSS) estimates and forecasts

Statistics highlight that Gossamer Bio Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 41.98% of value to its shares in past 6 months, showing an annual growth rate of 36.44% while that of industry is 12.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 63.50% in the current quarter and calculating 57.80% increase in the next quarter.

7 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of -$ for the same. And 7 analysts are in estimates of company making revenue of -$ in the next quarter that will end on Jun 2024. Company posted -$ and -$ of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 11.99% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 35.82% while estimates for its earnings growth in next 5 years are of 5.20%.

GOSS Dividends

Gossamer Bio Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.